Recruiting

Actívatexto

Sponsor:

University of Rochester

Code:

NCT06926608

Conditions

Smoking

Smoking Cessation

Physical Inactivity

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Actívatexto

Decídetexto

Study Details

Brief summary:

The purpose of this randomized controlled trial is to assess the efficacy of Actívatexto (Aim 1) and the mediators of the presumed treatment effect (Aim 2) among Latino adults who smoke. Actívatexto is a mobile intervention that integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy \[i.e., nicotine replacement therapies (NRT)\], and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.

Conditions

Smoking

Smoking Cessation

Physical Inactivity

Study ID

NCT06926608

Start date

Jun 17, 2025

Status verified date

Jul, 2025

Completion date

May 31, 2029

Anticipated

Primary completion date

May 31, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Self-identify as Hispanic and/or Latino
  • Know how to read and speak English and/or Spanish
  • Be ≥ 18 years of age
  • Not meet the recommended levels of physical activity (150 minutes of moderate to vigorous physical activity)
  • Smoke cigarettes at least 3 days per week
  • Be interested in quitting smoking in the next 30 days
  • Have a cellphone with text messaging capability
  • Know how to utilize text messages
  • Be willing to wear a wearable device daily to monitor physical activity
  • Be willing to complete all study visits

Exclusion Criteria:

  • Use of tobacco products other than cigarettes in the past 30 days (including e-cigarettes)
  • Being pregnant or breastfeeding
  • Plan to move from their current residence in the next six months
  • Another household member enrolled in the study
  • Unable to become more physically active or engage in a fitness appraisal

Study Design

Enrollment

408 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Actívatexto

Actívatexto is a mobile intervention that promotes both smoking cessation and physical activity. Actívatexto integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.

active comparator: Decídetexto

Decídetexto is a mobile intervention that solely promotes smoking cessation. Decídetexto integrates three components: 1) a text messaging program that solely promotes smoking cessation, 2) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 3) an online dashboard where the research team manages participants' incoming and outgoing data from the text messaging program.

Interventions

Actívatexto

Actívatexto is a mobile intervention that promotes both smoking cessation and physical activity. Actívatexto integrates four components: 1) a text messaging program that promotes both smoking cessation and physical activity, 2) wearable devices to monitor physical activity, 3) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 4) an online dashboard where the research team manages participants' incoming and outgoing data from both the text messaging program and wearable devices.

Decídetexto

Decídetexto is a mobile intervention that solely promotes smoking cessation. Decídetexto integrates three components: 1) a text messaging program that solely promotes smoking cessation, 2) smoking cessation pharmacotherapy (i.e., nicotine replacement therapies), and 3) an online dashboard where the research team manages participants' incoming and outgoing data from the text messaging program.

Primary outcome measure

  • Percent of participants with cotinine verified 7-day point prevalence abstinence [ Time Frame: Month 6 ]

Central Contacts and Locations

Central contacts

Francisco Cartujano, MD

(585) 273-1646francisco_cartujano@urmc.rochester.edu

Locations

University of Rochester Medical Center

Recruiting

Rochester, New York, United States, 14642

Contacts

Francisco Cartujano, MD

585-353-0035francisco_cartujano@urmc.rochester.edu

More Information

Sponsor

University of Rochester

Last update posted

Jul 8, 2025

Last verified

Jul, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Rochester on 2025-07-08.